Computational prediction of toxicity of small organic molecules: state-of-the-art

References

[1] Paul SM, Mytelka DS, Dunwiddie DT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov. 2010;9:203–14.10.1038/nrd3078Suche in Google Scholar PubMed

[2] Kennedy T. Managing the drug discovery/development interface. Drug Discov Today. 1997;2:436–44.10.1016/S1359-6446(97)01099-4Suche in Google Scholar

[3] Prentis RA, Lis Y, Walker SR. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985). Br J Clin Pharmacol. 1988;25:387–96.10.1111/j.1365-2125.1988.tb03318.xSuche in Google Scholar PubMed PubMed Central

[4] Caldwell GW. Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens. Curr Opin Drug Discov. 2000;3:30–41.10.2174/1567204043396677Suche in Google Scholar

[5] Sinko PJ. Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches. Curr Opin Drug Discov. 1999;2:42–8.Suche in Google Scholar

[6] Kharkar PS. In silico absorption, distribution, metabolism and excretion. In: Markus L, editor. In silico drug discovery and delivery. London: Future Science Group, 2013:149–62.Suche in Google Scholar

[7] Removing barriers to data sharing in pharmaceutical research and development. https://www.pharmaceutical-technology.com/features/removing-barriers-data-sharing-pharmaceutical-rd/. Accessed: 13 Jan 2019.Suche in Google Scholar

[8] This will change pharma as we know it – what will fuel innovation in healthcare? https://www.elsevier.com/connect/this-will-change-pharma-as-we-know-it-what-will-fuel-innovation-in-healthcare. Accessed: 13 Jan 2019.Suche in Google Scholar

[9] Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the human metabolome database. Nucleic Acids Res. 2007;35:D521–6.10.1093/nar/gkl923Suche in Google Scholar PubMed PubMed Central

[10] Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, et al. HMDB: A knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37:D603–10.10.1093/nar/gkn810Suche in Google Scholar PubMed PubMed Central

[11] Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. HMDB 3.0 — the human metabolome database in 2013. Nucleic Acids Res. 2013;41:D801–7.10.1093/nar/gks1065Suche in Google Scholar PubMed PubMed Central

[12] Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vázquez-Fresno R, et al. HMDB 4.0 — the human metabolome database for 2018. Nucleic Acids Res. 2018;46:D608–617.10.1093/nar/gkx1089Suche in Google Scholar PubMed PubMed Central

[13] TOXNET: the toxicology data network. https://toxnet.nlm.nih.gov/. Accessed: 13 Jan 2019.Suche in Google Scholar

[14] Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47:D1102–9.10.1093/nar/gky1033Suche in Google Scholar PubMed PubMed Central

[15] Benet LZ. Predicting pharmacokinetics/pharmacodynamics in the individual patient: separating reality from hype. J Clin Pharmacol. 2018;58:979–89.10.1002/jcph.1105Suche in Google Scholar PubMed

[16] Segall M. Integrating metabolism and toxicity properties. In: Wilson AGE, editor. RSC drug discovery series. new horizons in predictive drug metabolism and pharmacokinetics. London: Royal Society of Chemistry, 2015:227–44.10.1039/9781782622376-00227Suche in Google Scholar

[17] Yang Y, Zhao Y, Duan JZ, Zhao P, Zhao L, Zhang X. Predictive biopharmaceutics and pharmacokinetics: modeling and simulation. In: Qiu Y, Chen Y, Zhang GGZ, Yu L, Mantri RV, editors. Developing solid oral dosage forms: pharmaceutical theory & practice, 2nd ed. London: Academic Press, 2017:399–413.10.1016/B978-0-12-802447-8.00015-7Suche in Google Scholar

[18] Park M-N, Shin S-H, Byeon -J-J, Lee G-H, Yu B-Y, Shin YG. Prediction of pharmacokinetics and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach: A case study of caffeine and ciprofloxacin. Korean J Physiol Pharmacol. 2017;21:107–15.10.4196/kjpp.2017.21.1.107Suche in Google Scholar PubMed PubMed Central

[19] Nakayama K, Ito S, Suzuki M, Takubo H, Yamazaki H, Nomura Y. Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver. Xenobiotica. 2019;49:404–14.10.1080/00498254.2018.1460516Suche in Google Scholar PubMed

[20] Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066–72.10.1021/acs.jmedchem.5b00104Suche in Google Scholar PubMed PubMed Central

[21] Barbara S. Rofecoxib (Vioxx) voluntarily withdrawn from market. Can Med Assoc J. 2004;171:1027–8.10.1503/cmaj.1041606Suche in Google Scholar PubMed PubMed Central

[22] a) Ghosh J, Lawless MS, Waldman M, Gombar V, Fraczkiewicz R Modeling ADMET. In: Benfenati E, editor. In silico methods for predicting drug toxicity. New York: Hanuma Press, Springer Science+Business Media, 2016:63–83. (b) Mombelli E, Raitano G, Benfenati E. In silico prediction of chemically induced mutagenicity: how to use QSAR models and interpret their results. In: Benfenati E, editor. In silico methods for predicting drug toxicity. New York: Hanuma Press, Springer Science+Business Media, 2016:87–105; (c) Golbamaki A, Benfenati E. In silico methods for carcinogenicity assessment. In: Benfenati E, editor. In silico methods for predicting drug toxicity. New York: Hanuma Press, Springer Science+Business Media, 2016:107–19; (d) Marzo M, Roncaglioni A, Kulkarni S, Barton-Maclaren TS, Benfenati E. In silico model for developmental toxicity: how to use QSAR models and interpret their results. In: Benfenati E, editor. In silico methods for predicting drug toxicity. New York: Hanuma Press, Springer Science+Business Media, 2016:139–61; (e) Hewitt M, Przybylak K. In silico models for hepatotoxicity. In: Benfenati E, editor. In silico methods for predicting drug toxicity. New York: Hanuma Press, Springer Science+Business Media, 2016:201–36; (f) Roy K, Kar S. In silico models for ecotoxicity of pharmaceuticals. In: Benfenati E, editor. In silico methods for predicting drug toxicity. New York: Hanuma Press, Springer Science+Business Media, 2016:237–304.10.1007/978-1-4939-3609-0_4Suche in Google Scholar PubMed

[23] Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R1): Current Step 4 Version 2017. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/ Multidisciplinary/M7/M7_R1_Addendum_Step_4_31Mar2017.pdf. Accessed: 15 Jan 2019.Suche in Google Scholar

[24] Patel M, Kranz M, Munoz-Muriedas J, Harvey JS, Giddings A, Swallow S, et al. A pharma-wide approach to address the genotoxicity prediction of primary aromatic amines. Comput Toxicol. 2018;7:27–35.10.1016/j.comtox.2018.06.002Suche in Google Scholar

[25] Glück J, Buhrke T, Frenzel F, Braeuning A, Lampen A. In silico genotoxicity and carcinogenicity prediction for food-relevant secondary plant metabolites. Food Chem Toxicol. 2018;116:298–306.10.1016/j.fct.2018.04.024Suche in Google Scholar PubMed

[26] VEGA HUB. Virtual models for property Evaluation of chemicals within a Global Architecture. http://www.vega-qsar.eu/. Accessed: 15 Jan 2019.Suche in Google Scholar

[27] Lazar toxicity predictions. https://lazar.in-silico.ch/predict. Accessed: 15 Jan 2019; (a) Toxicity Estimation Software Tool (TEST). https://www.epa.gov/chemical-research/toxicity-estimation-software-tool-test. Accessed: 15 Jan 2019; (b) U.S. EPA (2016). User’s Guide for T.E.S.T. (version 4.2) (Toxicity Estimation Software Tool): A Program to Estimate Toxicity from Molecular Structure.Suche in Google Scholar

[28] (a) Toxicity Estimation Software Tool (TEST). https://www.epa.gov/chemical-research/toxicity-estimation-software-tool-test. Accessed: 15 Jan 2019. (b) U.S. EPA (2016). User’s Guide for T.E.S.T. (version 4.2) (Toxicity Estimation Software Tool): A Program to Estimate Toxicity from Molecular Structure.Suche in Google Scholar

[29] OECD QSAR ToolBox. http://www.oecd.org/chemicalsafety/risk-assessment/oecd-qsar-toolbox.htm. Accessed: 15 Jan 2019.Suche in Google Scholar

[30] Di Sotto A, Di Giacomo S, Abete L, Božović M, Parisi OA, Barile F, et al. Genotoxicity assessment of piperitenone oxide: an in vitro and in silico evaluation. Food Chem Toxicol. 2017;106(Pt A):506–13.10.1016/j.fct.2017.06.021Suche in Google Scholar PubMed

[31] a) Patlewicz G, Jeliazkova N, Safford RJ, Worth AP, Aleksiev B An evaluation of the implementation of the Cramer classification scheme in the Toxtree software. SAR QSAR Environ Res. 2008, 19, 495–524. b) Toxtree - Toxic hazard estimation by decision tree approach. http://toxtree.sourceforge.net/. Accessed: 17 Jan 2019.10.1080/10629360802083871Suche in Google Scholar PubMed

[32] Bossa C, Benigni R, Tcheremenskaia O, Battistelli CL. (Q)SAR methods for predicting genotoxicity and carcinogenicity: scientific rationale and regulatory f frameworks. In: Nicolotti O, editor. Computational toxicology: methods and protocols, methods in molecular biology. Vol. 1800. New York: Springer Science+Business Media, 2018:447–73.10.1007/978-1-4939-7899-1_20Suche in Google Scholar PubMed

[33] ReFaC. http://www.refac.eu/aboutus.aspx. Accessed: 17 Jan 2019.Suche in Google Scholar

[34] European Food Safety Authority (EFSA). http://www.efsa.europa.eu/. Accessed: 17 Jan 2019.Suche in Google Scholar

[35] Verheyen GR, Deun KV, Van Miert S. Testing the mutagenicity potential of chemicals. J Genet Genome Res. 2017;4:029.10.23937/2378-3648/1410029Suche in Google Scholar

[36] Valerio LG, Jr., Cross KP. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities. Toxicol Appl Pharmacol. 2012;260:209–21.10.1016/j.taap.2012.03.001Suche in Google Scholar PubMed

[37] Plošnik A, Vračko M, Dolenc MS Mutagenic and carcinogenic structural alerts and their mechanisms of action. Arh Hig Rada Toksikol. 2016;67:169–82.10.1515/aiht-2016-67-2801Suche in Google Scholar PubMed

[38] (a) MultiCASE Inc. Beachwood, OH, (www.multicase.com). 2018. (b) Saiakhov R, Chakravarti, S, Klopman, G. Effectiveness of CASE Ultra expert system in evaluating adverse effects of drugs. Mol Inform. 2013;32,87–97.Suche in Google Scholar

[39] Beck DE, Abdelmalak M, Lv W, Reddy PVN, Tender GS, O’Neill E, et al. Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore. J Med Chem. 2015;58:3997–4015.10.1021/acs.jmedchem.5b00303Suche in Google Scholar PubMed PubMed Central

[40] Fujita Y, Honda H, Yamane M, Morita T, Matsuda T, Morita O. A decision tree-based integrated testing strategy for tailor-made carcinogenicity evaluation of test substances using genotoxicity test results and chemical spaces. Mutagen. 2019;34:101–9.10.1093/mutage/gey039Suche in Google Scholar PubMed

[41] The OECD QSAR Toolbox version 4.1. https://www.qsartoolbox.org. Accessed: 19 Jan 2019.Suche in Google Scholar

[42] Fan D, Yang H, Li F, Sun L, Di P, Li W, et al. In silico prediction of chemical genotoxicity using machine learning methods and structural alerts. Toxicol Res (Camb). 2017;7:211–20.10.1039/C7TX00259ASuche in Google Scholar PubMed PubMed Central

[43] PaDEL-Descriptor. A software to calculate molecular descriptors and fingerprints. http://www.yapcwsoft.com/dd/padeldescriptor/. Accessed: 19 Jan 2019.Suche in Google Scholar

[44] Dong J, Yao Z, Zhu M, Wang N, Lu B, Chen A, et al. ChemSAR: an online pipelining platform for molecular SAR modeling. J Cheminf. 2017;9:1–13.10.1186/s13321-017-0215-1Suche in Google Scholar PubMed PubMed Central

[45] Orange 2.0 https://orange.biolab.si. Accessed: Jan 20, 2019.Suche in Google Scholar

[46] Ferrari T, Cattaneo D, Gini G, Bakhtyari NG, Manganaro A, Benfenati E. Automatic knowledge extraction from chemical structures: the case of mutagenicity prediction. SAR QSAR Environ Res. 2013;24:365–83.10.1080/1062936X.2013.773376Suche in Google Scholar PubMed

[47] Morita T, Shigeta Y, Kawamura T, Fujita Y, Honda H, Honma M. In silico prediction of chromosome damage: comparison of three (Q)SAR models. Mutagen. 2019;34:91–100.10.1093/mutage/gey017Suche in Google Scholar PubMed

[48] Organisation for Economic Co-operation and Development (OECD). https://www.oecd-ilibrary.org/. Accessed: 20 Jan 2019.Suche in Google Scholar

[49] Lu J, Zhang P, Zou XW, Zhao XQ, Cheng KG, Zhao YL, et al. In silico prediction of chemical toxicity profile using local lazy learning. Comb Chem High Throughput Screen. 2017;20:346–53.10.2174/1386207320666170217151826Suche in Google Scholar PubMed

[50] Zhang H, Ren JX, Kang YL, Bo P, Liang JY, Ding L, et al. Development of novel in silico model for developmental toxicity assessment by using naïve Bayes classifier method. Reprod Toxicol. 2017;71:8–15.10.1016/j.reprotox.2017.04.005Suche in Google Scholar PubMed

[51] Hessel EVS, Staal YCM, Piersma AH. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing. Toxicol Appl Pharmacol. 2018;354:136–52.10.1016/j.taap.2018.03.013Suche in Google Scholar PubMed

[52] López-Massaguer O, Pastor M, Sanz F, Carbonell P. Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data. Methods Mol Biol. 2018;1800:505–18.10.1007/978-1-4939-7899-1_23Suche in Google Scholar PubMed

[53] Carbonell P, Lopez O, Amberg A, Pastor M, Sanz F. Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data. ALTEX. 2017;34:219–34.10.14573/altex.1602071Suche in Google Scholar PubMed

[54] Zhang L, Zhang H, Ai H, Hu H, Li S, Zhao J, et al. Applications of machine learning methods in drug toxicity prediction. Curr Top Med Chem. 2018;18:987–97.10.2174/1568026618666180727152557Suche in Google Scholar PubMed

[55] Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257–W263.10.1093/nar/gky318Suche in Google Scholar PubMed PubMed Central

[56] ProTox-II – prediction of toxicity of chemicals. http://tox.charite.de/protox_II/. Accessed: 20 Jan 2019.Suche in Google Scholar

[57] Lu Y, Liu L, Lu D, Cai Y, Zheng M, Luo X, et al. Predicting hepatotoxicity of drug metabolites via an ensemble approach based on support vector machine. Comb Chem High Throughput Screen. 2017;20:839–49.10.2174/1386207320666171121113255Suche in Google Scholar PubMed

[58] Zhu XW, Li SJ. In silico prediction of drug-induced liver injury based on adverse drug reaction reports. Toxicol Sci. 2017;158:391–400.10.1093/toxsci/kfx099Suche in Google Scholar PubMed

[59] Ivanov S, Semin M, Lagunin A, Filimonov D, Poroikov V. In silico identification of proteins associated with drug-induced liver injury based on the prediction of drug-target interactions. Mol Inform. 2017;36:1600142.10.1002/minf.201600142Suche in Google Scholar PubMed

[60] Toropova AP, Toropov AA. CORAL: binary classifications (active/inactive) for drug-induced liver injury. Toxicol Lett. 2017;268:51–7.10.1016/j.toxlet.2017.01.011Suche in Google Scholar PubMed

[61] CORAL-QSAR/QSPR. http://www.insilico.eu/coral/. Accessed: 21 Jan 2019.Suche in Google Scholar

[62] Kar S, Roy K, Leszczynski J. Impact of pharmaceuticals on the environment: risk assessment using QSAR modeling approach. In: Nicolotti O, editor. Methods in molecular biology - computational toxicology: methods and protocols. New York, NY: Humana Press, 2018:395–443.10.1007/978-1-4939-7899-1_19Suche in Google Scholar PubMed PubMed Central

[63] de Morais E, Silva L, Alves MF, Scotti L, Lopes WS, Scotti MT. Predictive ecotoxicity of MoA 1 of organic chemicals using in silico approaches. Ecotoxicol Environ Saf. 2018;153:151–9.10.1016/j.ecoenv.2018.01.054Suche in Google Scholar PubMed

[64] Sangion A, Gramatica P. Hazard of pharmaceuticals for aquatic environment: prioritization by structural approaches and prediction of ecotoxicity. Environ Int. 2016;95:131–43.10.1016/j.envint.2016.08.008Suche in Google Scholar PubMed

[65] CASE Ultra Models. http://www.multicase.com/case-ultra-models#renaltox_bundle. Accessed: 21 Jan 2019.Suche in Google Scholar